Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Toronto
$4,950.00
Tissue origin determines the susceptibility of fibroblasts to mechanically induced fibrogenesis
FY 2012-13
Summary
Fibrosis is a major cause for organ failure with no effective therapy available. Fibrosis is characterized by the accumulation of a collagen-rich and stiff extracellular matrix. The stiffness of fibrotic tissues activates resident non-contractile fibroblastic cells into highly contractile myofibroblasts. Enhanced myofibroblast contraction is detrimental by producing the tissue contractures that impair organ function.Based on previous observations in the Hinz lab, we hypothesize that fibroblasts are heterogeneous in their ability to differentiate into fibrogenic myofibroblasts upon mechanical stimulation. The aim of this study is to evaluate whether the mechanical environment of their origin tissue influences the potential of fibroblasts to differentiate into myofibroblasts.
The research priority areas directly relevant to this proposal are 'Tissue Injury, Repair and Replacement' and 'Chronic Disease'. The project aims in understanding the role of contractile myofibroblasts in physiological tissue repair and in causing pathological and chronic tissue fibrosis. Fibrosis is a major burden for the Canadian Health Care System. It is estimated that 60-70% of all disease-related deaths are ultimately caused by fibrosis-related organ failure. To date, no therapy is effective to treat fibrosis. Long term benefits of the proposed research will be improved health of Canadians who are impacted by fibrosis, and recipients of implants and regenerative cell therapy. The understanding of cell regulation gained from this research is crucial for the rational design of more efficient therapies for fibrocontractive diseases. In particular, anti-fibrosis therapies may need to be tuned to different fibroblast populations in different organs.
Department
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
278045
Name
Guo Suzette
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Tissue origin determines the susceptibility of fibroblasts to mechanically induced fibrogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Cell Contraction; Fibrosis; Myofibroblast; Oncology; Tissue Repair; Wound Healing
Abstract
Fibrosis is a major cause for organ failure with no effective therapy available. Fibrosis is characterized by the accumulation of a collagen-rich and stiff extracellular matrix. The stiffness of fibrotic tissues activates resident non-contractile fibroblastic cells into highly contractile myofibroblasts. Enhanced myofibroblast contraction is detrimental by producing the tissue contractures that impair organ function.Based on previous observations in the Hinz lab, we hypothesize that fibroblasts are heterogeneous in their ability to differentiate into fibrogenic myofibroblasts upon mechanical stimulation. The aim of this study is to evaluate whether the mechanical environment of their origin tissue influences the potential of fibroblasts to differentiate into myofibroblasts.
The research priority areas directly relevant to this proposal are 'Tissue Injury, Repair and Replacement' and 'Chronic Disease'. The project aims in understanding the role of contractile myofibroblasts in physiological tissue repair and in causing pathological and chronic tissue fibrosis. Fibrosis is a major burden for the Canadian Health Care System. It is estimated that 60-70% of all disease-related deaths are ultimately caused by fibrosis-related organ failure. To date, no therapy is effective to treat fibrosis. Long term benefits of the proposed research will be improved health of Canadians who are impacted by fibrosis, and recipients of implants and regenerative cell therapy. The understanding of cell regulation gained from this research is crucial for the rational design of more efficient therapies for fibrocontractive diseases. In particular, anti-fibrosis therapies may need to be tuned to different fibroblast populations in different organs.
Competitiondate
201301
Approvedterm2
0 yr 3 mths
Pinamesdelim
Guo, Suzette
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~